openPR Logo
Press release

Cancer Tumor Organoids To Transform Cancer Therapy Market With USD 400 Million Opportunity

01-28-2020 09:02 AM CET | Health & Medicine

Press release from: Kuick Resarch

In cancer biology, an important aspect of developing a personalized anti-cancer therapy is by reconstructing the heterogeneity in the cancer models with respect to the specific patient. All along, the emergence of cancer organoids as an approach to create the cancer model derived from the patient with the unique property of resembling the pathophysiological features of the in-vivo tumor is however considered a breakthrough in the world where cancer cases are increasing every year by a high rate.

The research report "Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025" prepared with complete in-sight about the cancer organoids market and presents the exponential growth of the technology followed by the current market trends accompanied by the technology at the application level as well as global and regional level. The report discusses the feasibility of the technology with respect to its generation cost and accomplishment within short period of time, advantages over the other technologies and the ease of use. The whole market segment in the research report of cancer organoids is attributed towards the platform it provides for the personalized medicine, drug discovery, drug development and drug efficacy testing.

Download Report: https://www.kuickresearch.com/report-global-cancer-tumor-organoids-modeling,-technology-and-personalized-cancer-research-insight-2025.php

The technology is already considered as an advanced clinical breakthrough and the methodologies followed by the technology has been already established as a promising tool in many basic as well as advanced clinical and sub-clinical applications. The in-vitro 3D model of the in-vivo tumor facilitates a precised study of a variety of the physiological processes including drug development, the response of the cells to drugs, in-vivo mutations and the tissue renewal status. The cancer biologists with such advanced technology in lab have transformed the utilization of traditional 2D cells lines with 3D model system in the research community.

Cancer organoids are deigned to achieve a more novel, sophisticated clinical trials with the potential to develop a treatment regarding the regimens of the patient's tumor. The technology conveniently excludes the pain that a patient might undergo when subjected to a non-beneficial treatment. Therefore, the potential of the technology to cut off the pain and adverse issues associated with the blind treatment of cancer makes it a more appropriate and feasible treatment method.

It is well-noticed that the unraveling of the applications from the technology has opened up new avenues for the discovery and development of novel drugs and treatments. The clinicians are dependent on the technology to correct the condition of the cancer patient and however the technology is successful in conducting an environment that is favoring the health of the patient. Cancer organoids offers a future full of the potentials received from it and a better scenario for investigating treatment responses for a specific patient, thus heading towards a brighter precision medicine market.

Contact:
Neeraj Chawla
neeraj@kuickresearch.com
+91-11-47067990

Delhi,India,Tel +91-11-47067990

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Tumor Organoids To Transform Cancer Therapy Market With USD 400 Million Opportunity here

News-ID: 1910477 • Views: 170

More Releases from Kuick Resarch

Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …
"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research" "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs • Marketed Cancer Antibody Drug Conjugate: 9 Drugs • Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 • Majority of Drug Trials Are For Second Line Therapy
Global Cell Therapy Market Stem Cell Therapy Market Size Sales Growth Clinical T …
Global Cell Therapy Market Size Sales Opportunity To Surpass USD 40 Billion By 2027 Says Kuick Research Report Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027 "Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market: > USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Cell Therapy Price & Product Insight By Region/Country • Clinical
Global Small Molecule Targeted Cancer Drug Market Size Sales To Reach US$ 130 Bi …
"Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Small Molecule Cancer Drug Market: > US$ 125 Billion by 2026 • USA Dominates Global Small Molecule Cancer Drug Market: >50% Share • Number of Small Molecule Cancer Drugs In Clinical Trials: >2500 Drugs • Small Molecule Cancer Drugs Dosage, Sales, Price & Patent Insight: 175 Drugs • Small Molecule Drug Insight by Cancer • Clinical Trials Insight
GCC Clinical Trial Market Outlook Insight 2025
"GCC Clinical Trial Market Outlook 2025" Report Highlights: • GCC Clinical Trial Market Opportunity: >US$ 500 Million • GCC Disease Prevalence & Statistics • Saudi Arabia Dominating GCC Clinical Trial Landscape: > 500 Trials • Clinical Trials for Cancer in GCC: > 120 Trials • Guidelines For Conducting Clinical Trials by Country • Ongoing Clinical Trials Insight by Country Download Report: https://www.kuickresearch.com/report-report-report-report-report-report-report-report-gcc-clinical-trial-market-size-number--data-regulation-registration Table of Contents 1. GCC Clinical Market Regional Insights 2. GCC Clinical Trial Market Dynamics 2.1 Driving Forces for GCC Clinical Trial

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Natural Cancer Treatment
Cancer is going to be the number one killer in the world beginning from the year 2010! Facts of Cancer Cancer is a group of over 100 diseases that cause the cells in your body to grow to an uncontrollable level, as their normal growth regulating mechanism experiences an imbalance due to numerous external and internal factors. Many of the reasons for this scenario to occur are still unknown to medical science. However,
Mesothelioma: The “Orphan” Cancer
Government funding remains elusive for deadly disease Newton, MA. Oct. 1st 2007. While Americans have long been romanced by campaigns for breast cancer and leukemia research, it may be some time before mesothelioma enjoys a stint in the spotlight. Despite the fact that over 2,500 cases of the disease are diagnosed in the U.S. each year—with as many or more dying from it—the need to develop effective treatments for mesothelioma victims